VQD-002 triciribine phosphate monohydrate regulatory update

FDA granted Orphan Drug designation for VioQuest's VQD-002 to treat multiple myeloma. The tricyclic nucleoside inhibitor of Akt phosphorylation is in Phase I testing to treat solid tumors and hematolo...